2B. A. Stemerdink,A. F. Kalverboer,J. J. van der Meere,M. W. van der Molen,J. Huisman,L. W. A. de Jong,F. M. E. Slijper,P. H. Verkerk,F. J. van Spronsen. Behaviour and school achievement in patients with early and continuously treated phenylketonuria[J] 2000,Journal of Inherited Metabolic Disease(6):548～562
3Friedrich K. Trefz,Sanja Cipcic-Schmidt,Richard Koch. Final intelligence in late treated patients with phenylketonuria[J] 2000,European Journal of Pediatrics(2):S145～S148
4J. Weglage,M. Grenzebach,M. Pietsch,R. Feldmann,R. Linnenbank,J. Denecke,H. G. Koch. Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls[J] 2000,Journal of Inherited Metabolic Disease(5):487～496
二级参考文献8
1Ludolph AC,Ullrich K,Nedjat S,Masur H,Bick U.Neurological outcome in 22 treated adolescents with hyperphenylalaninaemia.A clinical and electrophysiological study[J].Acta Neurol Scand,1992,85 (5):243-248.
2Phillips MD,McGraw P,Lowe MJ,Mathews VP,Hainline BE.Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria[J].AJNR Am J Neuroradiol,2001,22(8):1583-1586.
3Cleary MA,Walter JH,Wraith JE,Jenkins JP,Alani SM,Tyler K,et al.Magnetic resonance imaging of the brain in phenylketonuria[J].Lancet,1994,344(8915):87-90.
4Thompson AJ,Tillotson S,Smith I.Brain MRI changes in phenylketonuria:Associations with dietary status[J].Brain,1993,116(Pt4):811-821.
5Forsting M.MR imaging of the brain:metabolic and toxic white matter diseases[J].Eur Radiol,1999,9 (6):1061-1065.
6Channon S,German E,Cassina C,Lee P.Executive functioning,memory,and learning in phenylketonuria[J].Neuropsychology,2004,18(4):613-620.
